Contact: Eric Schoch
Caption: Researchers from Indiana University, the University of Michigan, the Fred Hutchinson Cancer Research Center and the Dana-Farber Cancer Institute have identified and validated a biomarker accessible in blood tests that could be used to predict which stem cell transplant patients are at highest risk for a potentially fatal immune response called graft-versus-host disease.
Credit: Indiana University
Usage Restrictions: None
Related news release: Scientists identify biomarker to predict immune response risk after stem cell transplants